Injections for giddiness

I'll look up the medical library for information on injections used for giddiness (vertigo/dizziness).
Searching sources...
Reading File
Finding Sources
Finding Sources
Searching the Web

injections for vertigo giddiness treatment prochlorperazine betahistine

Reading File
Reading File
Finding Sources
Reading File
Reading File
Here is a thorough, textbook-sourced overview of injections used for giddiness (vertigo):

Injections for Giddiness (Vertigo)

Giddiness/vertigo is managed with several injectable drugs depending on the setting - acute attacks in the emergency department, refractory Meniere's disease, or vestibular neuritis. Treatment falls into symptomatic (vestibular suppressants) and specific (disease-modifying) categories.

1. Symptomatic Injections (Acute Vertigo Attack)

Ondansetron (IV) - First Line

  • Dose: 4 mg IV
  • A 5-HT3 serotonin receptor antagonist; used as the first-line IV agent for symptomatic vertigo in the emergency setting
  • A randomized trial comparing IM promethazine vs IV ondansetron in acute peripheral vertigo showed excellent improvement in both groups, with fewer side effects with ondansetron
    • Rosen's Emergency Medicine, p. 3856

Promethazine (IM) - Highly Effective but Caution Needed

  • Dose: 12.5-25 mg IM; also available as 25 mg suppository
  • Likely the most effective parenteral vestibular suppressant, but the FDA has issued a boxed warning against IV use (risk of tissue necrosis); IM or oral routes are preferred
  • Useful when vomiting prevents oral intake
    • Rosen's Emergency Medicine, p. 3854-3856

Prochlorperazine (IV/IM) - Dopamine Antagonist

  • Dose: 5-10 mg IV or IM (Stemetil®)
  • A phenothiazine dopamine antagonist that blocks the chemoreceptor trigger zone and vomiting centre, which receives afferent input from the vestibular apparatus
  • Available as injection, tablets, suppositories, and buccal preparation (Buccastem®) - the non-oral forms are particularly useful since vomiting patients cannot absorb oral doses
  • Notable side effects: extra-pyramidal effects (more pronounced than other phenothiazines), less sedating
  • Do NOT use in dizziness caused by orthostatic hypotension
    • Scott-Brown's Otorhinolaryngology, p. 4545-4565

Diazepam (IV) - Benzodiazepine

  • Dose: 5 mg IV
  • Useful in prolonged, severe vertigo episodes; patients prefer lying still in a dark quiet room and this agent helps
  • Benzodiazepines (e.g., lorazepam 1-2 mg IV) can be given when vertigo is intractable and unresponsive to antiemetics
  • Caution: Not recommended for discharge prescriptions in vestibular neuritis/labyrinthitis as benzodiazepines interfere with vestibular habituation/compensation
    • Goldman-Cecil Medicine, p. 3564; Rosen's Emergency Medicine, p. 3856

Cyclizine (IM) - Antihistamine

  • Dose: 50 mg three times a day, may be given parenterally
  • H1-receptor antagonist; acts mainly on the vomiting centre
  • Less sedating than promethazine
    • Scott-Brown's Otorhinolaryngology, p. 4581-4583

2. Specific / Disease-Modifying Injections

Intratympanic Gentamicin - Meniere's Disease

  • Injected through the tympanic membrane (or via grommet/round window catheter) directly into the middle ear
  • Exploits gentamicin's vestibulotoxic effect - destroys vestibular hair cell function ("chemical/partial labyrinthectomy")
  • Highly effective for controlling recurrent vertigo attacks in refractory unilateral Meniere's disease
  • Risk: Hearing loss (varies with dose and frequency)
    • Scott-Brown's Otorhinolaryngology, p. 4588-4595

Intratympanic Methylprednisolone / Dexamethasone - Meniere's Disease

  • Injected intratympanically for refractory vertigo in Meniere's disease
  • Intratympanic methylprednisolone is comparable to intratympanic gentamicin in reducing vertiginous attacks but preserves hearing - preferred when residual hearing needs to be protected
  • Intratympanic dexamethasone achieved substantial vertigo control in ~61% of patients in one series
    • Goldman-Cecil Medicine, p. 3562; Scott-Brown's Vol 2, p. 6326

Methylprednisolone (systemic IV/IM) - Vestibular Neuritis

  • Dose: 1 mg/kg/day for 5 days, then tapered over 15 days
  • Effective (at least short-term) for vestibular neuritis; antiviral agents have NOT been shown to add benefit
    • Goldman-Cecil Medicine, p. 3562

3. Summary Table

DrugRouteDoseMain Use
OndansetronIV4 mgAcute vertigo (1st line IV)
PromethazineIM12.5-25 mgAcute vertigo with vomiting
ProchlorperazineIV/IM5-10 mgAcute vertigo/nausea
Diazepam/LorazepamIV5 mg / 1-2 mgSevere/intractable vertigo
CyclizineIM50 mgAcute vertigo (antihistamine)
MethylprednisoloneIV/IM (systemic)1 mg/kg/dayVestibular neuritis
Intratympanic gentamicinIntratympanicVariableRefractory Meniere's (ablative)
Intratympanic steroidIntratympanicVariableRefractory Meniere's (hearing preserved)

Key Clinical Points

  • Acute attacks: Start with IV ondansetron 4 mg; use IM promethazine if needed (avoid IV route)
  • Intractable vertigo unresponsive to antiemetics: Add IV lorazepam 1-2 mg
  • Vestibular neuritis: Systemic corticosteroids (methylprednisolone); avoid prolonged benzodiazepines
  • Refractory Meniere's with good hearing: Intratympanic steroids preferred over gentamicin
  • Refractory Meniere's, hearing already lost: Intratympanic gentamicin for definitive vestibular ablation
  • Do not use prochlorperazine or chlorpromazine if dizziness is from orthostatic hypotension
This is a shared conversation. Sign in to Orris to start your own chat.